FDA Approves First Treatment for NASH-Related Liver Scarring
U.S. Food and Drug Administration
The FDA granted the approval of Rezdiffra to Madrigal Pharmaceuticals
Per the WHO records, more than 39 million people were living with HIV at the end of 2022
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease